Geron | L'Utile Operativo



Operating Profit Cambiamento Data
Amgen USD 2.31B 182M 2024-12
Bio Techne USD 47.42M 7.43M 2024-12
Cassava Sciences USD -29487000 1.14M 2024-12
Cytokinetics USD -139040000 1.76M 2024-12
Exelixis USD 163.21M 27.13M 2025-01
Genmab DKK 2.19B 89M 2024-12
Geron USD -21757000 6.46M 2024-12
Gilead Sciences USD 2.45B 1.56B 2024-12
Incyte USD 301.51M 155.43M 2024-12
MacroGenics USD 54.19M 112.37M 2024-09
Novartis USD 2.28B 1.34B 2024-12



Geron L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.